Please Wait.....
Report
Drug Discovery Outsourcing Market (Workflow: Target Identification & Screening, Lead Identification & Candidate Optimization, Development of Disease Models, Pre-formulation Studies, Entire Clinical Trials, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
Market Report I 2023-07-07 I 214 Pages I Transparency Market Research
Drug Discovery Outsourcing Market - Scope of Report
TMR's report on the global drug discovery outsourcing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global drug discovery outsourcing market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global drug discovery outsourcing market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the drug discovery outsourcing market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global drug discovery outsourcing market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global drug discovery outsourcing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global drug discovery outsourcing market.
The report delves into the competitive landscape of the global drug discovery outsourcing market. Key players operating in the global drug discovery outsourcing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global drug discovery outsourcing market profiled in this report.
Key Questions Answered in Global Drug Discovery Outsourcing Market Report
- What is the sales/revenue generated by drug discovery outsourcing across all regions during the forecast period?
- What are the opportunities in the global drug discovery outsourcing market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2031?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Drug Discovery Outsourcing Market - Research Objectives and Research Approach
The comprehensive report on the global drug discovery outsourcing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global drug discovery outsourcing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global drug discovery outsourcing market.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Drug Discovery Outsourcing Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Drug Discovery Outsourcing Market Analysis and Forecast, 2017-2031
5. Key Insights
5.1. Technological Advancements
5.2. Overview: Integrated Drug Discovery (IDD) outsourcing
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type, 2017-2031
6.3.1. Chemistry Services
6.3.2. Biology Services
6.4. Market Attractiveness Analysis, by Type
7. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Drug Molecule
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Drug Molecule, 2017-2031
7.3.1. Small Molecules
7.3.2. Large Molecules
7.4. Market Attractiveness Analysis, by Drug Molecule
8. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Discovery Approach
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Discovery Approach, 2017-2031
8.3.1. Empirical Drug Discovery
8.3.2. Rational Drug Discovery
8.4. Market Attractiveness Analysis, by Discovery Approach
9. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Therapeutic Area
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Therapeutic Area, 2017-2031
9.3.1. Anti-infective
9.3.2. Cardiovascular
9.3.3. Central Nervous System
9.3.4. Dermatology
9.3.5. Endocrine
9.3.6. Gastrointestinal
9.3.7. Genitourinary System
9.3.8. Immunomodulation
9.3.9. Oncology
9.3.10. Ophthalmology
9.3.11. Respiratory System
9.3.12. Others
9.4. Market Attractiveness Analysis, by Therapeutic Area
10. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Workflow
10.1. Introduction & Definition
10.2. Key Findings/Developments
10.3. Market Value Forecast, by Workflow, 2017-2031
10.3.1. Target Identification and Screening
10.3.2. Lead Identification and Candidate Optimization
10.3.3. Development of Disease Models
10.3.4. Pre-formulation Studies
10.3.5. Entire Clinical Trials
10.3.6. Others
10.4. Market Attractiveness Analysis, by Workflow
11. Global Drug Discovery Outsourcing Market Analysis and Forecast, by End-user
11.1. Introduction & Definition
11.2. Key Findings/Developments
11.3. Market Value Forecast, by Discovery Approach, 2017-2031
11.3.1. Pharmaceutical Companies
11.3.2. Biotechnology Companies
11.3.3. Academic Institutes
11.4. Market Attractiveness Analysis, by End-user
12. Global Drug Discovery Outsourcing Market Analysis and Forecast, by Region
12.1. Key Findings
12.2. Market Value Forecast, by Region, 2017-2031
12.2.1. North America
12.2.2. Europe
12.2.3. Asia Pacific
12.2.4. Latin America
12.2.5. Middle East & Africa
12.3. Market Attractiveness Analysis, by Region
13. North America Drug Discovery Outsourcing Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2017-2031
13.2.1. Chemistry Services
13.2.2. Biology Services
13.3. Market Value Forecast, by Drug Molecule, 2017-2031
13.3.1. Small Molecules
13.3.2. Large Molecules
13.4. Market Value Forecast, by Discovery Approach, 2017-2031
13.4.1. Empirical Drug Discovery
13.4.2. Rational Drug Discovery
13.5. Market Value Forecast, by Therapeutic Area, 2017-2031
13.5.1. Anti-infective
13.5.2. Cardiovascular
13.5.3. Central Nervous System
13.5.4. Dermatology
13.5.5. Endocrine
13.5.6. Gastrointestinal
13.5.7. Genitourinary System
13.5.8. Immunomodulation
13.5.9. Oncology
13.5.10. Ophthalmology
13.5.11. Respiratory System
13.5.12. Others
13.6. Market Value Forecast, by Workflow, 2017-2031
13.6.1. Target Identification and Screening
13.6.2. Lead Identification and Candidate Optimization
13.6.3. Development of Disease Models
13.6.4. Pre-formulation Studies
13.6.5. Entire Clinical Trials
13.6.6. Others
13.7. Market Value Forecast, by End-user, 2017-2031
13.7.1. Pharmaceutical Companies
13.7.2. Biotechnology Companies
13.7.3. Academic Institutes
13.8. Market Value Forecast, by Country, 2017-2031
13.8.1. U.S.
13.8.2. Canada
13.9. Market Attractiveness Analysis
13.9.1. By Type
13.9.2. By Drug Molecule
13.9.3. By Discovery Approach
13.9.4. By Therapeutic Area
13.9.5. By Workflow
13.9.6. By End-user
13.9.7. By Country
14. Europe Drug Discovery Outsourcing Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type, 2017-2031
14.2.1. Chemistry Services
14.2.2. Biology Services
14.3. Market Value Forecast, by Drug Molecule, 2017-2031
14.3.1. Small Molecules
14.3.2. Large Molecules
14.4. Market Value Forecast, by Discovery Approach, 2017-2031
14.4.1. Empirical Drug Discovery
14.4.2. Rational Drug Discovery
14.5. Market Value Forecast, by Therapeutic Area, 2017-2031
14.5.1. Anti-infective
14.5.2. Cardiovascular
14.5.3. Central Nervous System
14.5.4. Dermatology
14.5.5. Endocrine
14.5.6. Gastrointestinal
14.5.7. Genitourinary System
14.5.8. Immunomodulation
14.5.9. Oncology
14.5.10. Ophthalmology
14.5.11. Respiratory System
14.5.12. Others
14.6. Market Value Forecast, by Workflow, 2017-2031
14.6.1. Target Identification and Screening
14.6.2. Lead Identification and Candidate Optimization
14.6.3. Development of Disease Models
14.6.4. Pre-formulation Studies
14.6.5. Entire Clinical Trials
14.6.6. Others
14.7. Market Value Forecast, by End-user, 2017-2031
14.7.1. Pharmaceutical Companies
14.7.2. Biotechnology Companies
14.7.3. Academic Institutes
14.8. Market Value Forecast, by Country/Sub-region, 2017-2031
14.8.1. Germany
14.8.2. U.K.
14.8.3. France
14.8.4. Italy
14.8.5. Spain
14.8.6. Rest of Europe
14.9. Market Attractiveness Analysis
14.9.1. By Type
14.9.2. By Drug Molecule
14.9.3. By Discovery Approach
14.9.4. By Therapeutic Area
14.9.5. By Workflow
14.9.6. By End-user
14.9.7. By Country/Sub-region
15. Asia Pacific Drug Discovery Outsourcing Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Type, 2017-2031
15.2.1. Chemistry Services
15.2.2. Biology Services
15.3. Market Value Forecast, by Drug Molecule, 2017-2031
15.3.1. Small Molecules
15.3.2. Large Molecules
15.4. Market Value Forecast, by Discovery Approach, 2017-2031
15.4.1. Empirical Drug Discovery
15.4.2. Rational Drug Discovery
15.5. Market Value Forecast, by Therapeutic Area, 2017-2031
15.5.1. Anti-infective
15.5.2. Cardiovascular
15.5.3. Central Nervous System
15.5.4. Dermatology
15.5.5. Endocrine
15.5.6. Gastrointestinal
15.5.7. Genitourinary System
15.5.8. Immunomodulation
15.5.9. Oncology
15.5.10. Ophthalmology
15.5.11. Respiratory System
15.5.12. Others
15.6. Market Value Forecast, by Workflow, 2017-2031
15.6.1. Target Identification and Screening
15.6.2. Lead Identification and Candidate Optimization
15.6.3. Development of Disease Models
15.6.4. Pre-formulation Studies
15.6.5. Entire Clinical Trials
15.6.6. Others
15.7. Market Value Forecast, by End-user, 2017-2031
15.7.1. Pharmaceutical Companies
15.7.2. Biotechnology Companies
15.7.3. Academic Institutes
15.8. Market Value Forecast, by Country/Sub-region, 2017-2031
15.8.1. China
15.8.2. Japan
15.8.3. India
15.8.4. Australia & New Zealand
15.8.5. Rest of Asia Pacific
15.9. Market Attractiveness Analysis
15.9.1. By Type
15.9.2. By Drug Molecule
15.9.3. By Discovery Approach
15.9.4. By Therapeutic Area
15.9.5. By Workflow
15.9.6. By End-user
15.9.7. By Country/Sub-region
16. Latin America Drug Discovery Outsourcing Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast, by Type, 2017-2031
16.2.1. Chemistry Services
16.2.2. Biology Services
16.3. Market Value Forecast, by Drug Molecule, 2017-2031
16.3.1. Small Molecules
16.3.2. Large Molecules
16.4. Market Value Forecast, by Discovery Approach, 2017-2031
16.4.1. Empirical Drug Discovery
16.4.2. Rational Drug Discovery
16.5. Market Value Forecast, by Therapeutic Area, 2017-2031
16.5.1. Anti-infective
16.5.2. Cardiovascular
16.5.3. Central Nervous System
16.5.4. Dermatology
16.5.5. Endocrine
16.5.6. Gastrointestinal
16.5.7. Genitourinary System
16.5.8. Immunomodulation
16.5.9. Oncology
16.5.10. Ophthalmology
16.5.11. Respiratory System
16.5.12. Others
16.6. Market Value Forecast, by Workflow, 2017-2031
16.6.1. Target Identification and Screening
16.6.2. Lead Identification and Candidate Optimization
16.6.3. Development of Disease Models
16.6.4. Pre-formulation Studies
16.6.5. Entire Clinical Trials
16.6.6. Others
16.7. Market Value Forecast, by End-user, 2017-2031
16.7.1. Pharmaceutical Companies
16.7.2. Biotechnology Companies
16.7.3. Academic Institutes
16.8. Market Value Forecast, by Country/Sub-region, 2017-2031
16.8.1. Brazil
16.8.2. Mexico
16.8.3. Rest of Latin America
16.9. Market Attractiveness Analysis
16.9.1. By Type
16.9.2. By Drug Molecule
16.9.3. By Discovery Approach
16.9.4. By Therapeutic Area
16.9.5. By Workflow
16.9.6. By End-user
16.9.7. By Country/Sub-region
17. Middle East & Africa Drug Discovery Outsourcing Market Analysis and Forecast
17.1. Introduction
17.1.1. Key Findings
17.2. Market Value Forecast, by Type, 2017-2031
17.2.1. Chemistry Services
17.2.2. Biology Services
17.3. Market Value Forecast, by Drug Molecule, 2017-2031
17.3.1. Small Molecules
17.3.2. Large Molecules
17.4. Market Value Forecast, by Discovery Approach, 2017-2031
17.4.1. Empirical Drug Discovery
17.4.2. Rational Drug Discovery
17.5. Market Value Forecast, by Therapeutic Area, 2017-2031
17.5.1. Anti-infective
17.5.2. Cardiovascular
17.5.3. Central Nervous System
17.5.4. Dermatology
17.5.5. Endocrine
17.5.6. Gastrointestinal
17.5.7. Genitourinary System
17.5.8. Immunomodulation
17.5.9. Oncology
17.5.10. Ophthalmology
17.5.11. Respiratory System
17.5.12. Others
17.6. Market Value Forecast, by Workflow, 2017-2031
17.6.1. Target Identification and Screening
17.6.2. Lead Identification and Candidate Optimization
17.6.3. Development of Disease Models
17.6.4. Pre-formulation Studies
17.6.5. Entire Clinical Trials
17.6.6. Others
17.7. Market Value Forecast, by End-user, 2017-2031
17.7.1. Pharmaceutical Companies
17.7.2. Biotechnology Companies
17.7.3. Academic Institutes
17.8. Market Value Forecast, by Country/Sub-region, 2017-2031
17.8.1. GCC Countries
17.8.2. South Africa
17.8.3. Rest of MEA
17.9. Market Attractiveness Analysis
17.9.1. By Type
17.9.2. By Drug Molecule
17.9.3. By Discovery Approach
17.9.4. By Therapeutic Area
17.9.5. By Workflow
17.9.6. By End-user
17.9.7. By Country/Sub-region
18. Competition Landscape
18.1. Market Player - Competitive Matrix (by tier and size of companies)
18.2. Market Share Analysis, by Company (2022)
18.3. Company Profiles
18.3.1. Charles River Laboratories International, Inc.
18.3.1.1. Company Overview
18.3.1.2. Product Portfolio
18.3.1.3. SWOT Analysis
18.3.1.4. Financial Overview
18.3.1.5. Strategic Overview
18.3.2. WuXi AppTec Co., Ltd.
18.3.2.1. Company Overview
18.3.2.2. Product Portfolio
18.3.2.3. SWOT Analysis
18.3.2.4. Financial Overview
18.3.2.5. Strategic Overview
18.3.3. Albany Molecular Research Inc.
18.3.3.1. Company Overview
18.3.3.2. Product Portfolio
18.3.3.3. SWOT Analysis
18.3.3.4. Financial Overview
18.3.3.5. Strategic Overview
18.3.4. GVK Biosciences Private Limited
18.3.4.1. Company Overview
18.3.4.2. Product Portfolio
18.3.4.3. SWOT Analysis
18.3.4.4. Financial Overview
18.3.4.5. Strategic Overview
18.3.5. Sygnature Discovery
18.3.5.1. Company Overview
18.3.5.2. Product Portfolio
18.3.5.3. SWOT Analysis
18.3.5.4. Financial Overview
18.3.5.5. Strategic Overview
18.3.6. Pharmaron Beijing Co., Ltd.
18.3.6.1. Company Overview
18.3.6.2. Product Portfolio
18.3.6.3. SWOT Analysis
18.3.6.4. Financial Overview
18.3.6.5. Strategic Overview
18.3.7. Domainex Ltd.
18.3.7.1. Company Overview
18.3.7.2. Product Portfolio
18.3.7.3. SWOT Analysis
18.3.7.4. Financial Overview
18.3.7.5. Strategic Overview
18.3.8. Thermo Fisher Scientific, Inc.
18.3.8.1. Company Overview
18.3.8.2. Product Portfolio
18.3.8.3. SWOT Analysis
18.3.8.4. Financial Overview
18.3.8.5. Strategic Overview
18.3.9. Jubilant Biosys Ltd.
18.3.9.1. Company Overview
18.3.9.2. Product Portfolio
18.3.9.3. SWOT Analysis
18.3.9.4. Financial Overview
18.3.9.5. Strategic Overview
18.3.10. Evotec SE
18.3.10.1. Company Overview
18.3.10.2. Product Portfolio
18.3.10.3. SWOT Analysis
18.3.10.4. Financial Overview
18.3.10.5. Strategic Overview
18.3.11. Eurofins Discovery
18.3.11.1. Company Overview
18.3.11.2. Product Portfolio
18.3.11.3. SWOT Analysis
18.3.11.4. Financial Overview
18.3.11.5. Strategic Overview
18.3.12. GenScript Biotech Corporation
18.3.12.1. Company Overview
18.3.12.2. Product Portfolio
18.3.12.3. SWOT Analysis
18.3.12.4. Financial Overview
18.3.12.5. Strategic Overview
List of Tables
Table 01: Global Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Workflow, 2017-2031
Table 02: Global Drug Discovery Outsourcing Market Value () Forecast, by Drug Molecule, 2017-2031
Table 03: Global Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Discovery Approach, 2017-2031
Table 04: Global Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Therapeutic Area, 2017-2031
Table 05: Global Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Type, 2017-2031
Table 06: Global Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by End-user, 2017-2031
Table 07: Global Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Region, 2017-2031
Table 08: North America Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Workflow, 2017-2031
Table 09: North America Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Drug Molecule, 2017-2031
Table 10: North America Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Discovery Approach, 2017-2031
Table 11: North America Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Therapeutic Area, 2017-2031
Table 12: North America Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Type, 2017-2031
Table 13: North America Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by End-user, 2017-2031
Table 14: North America Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Country, 2017-2031
Table 15: Europe Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Workflow, 2017-2031
Table 16: Europe Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Drug Molecule, 2017-2031
Table 17: Europe Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Discovery Approach, 2017-2031
Table 18: Europe Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Therapeutic Area, 2017-2031
Table 19: Europe Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Type, 2017-2031
Table 20: Europe Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by End-user, 2017-2031
Table 21: Europe Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
Table 22: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Workflow, 2017-2031
Table 23: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Drug Molecule, 2017-2031
Table 24: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Discovery Approach, 2017-2031
Table 25: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Therapeutic Area, 2017-2031
Table 26: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Type, 2017-2031
Table 27: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by End-user, 2017-2031
Table 28: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
Table 29: Latin America Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Workflow, 2017-2031
Table 30: Latin America Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Drug Molecule, 2017-2031
Table 31: Latin America Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Discovery Approach, 2017-2031
Table 32: Latin America Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Therapeutic Area, 2017-2031
Table 33: Latin America Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Type, 2017-2031
Table 34: Latin America Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by End-user, 2017-2031
Table 35: Latin America Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
Table 36: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Workflow, 2017-2031
Table 37: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Drug Molecule, 2017-2031
Table 38: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Discovery Approach, 2017-2031
Table 39: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Therapeutic Area, 2017-2031
Table 40: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Type, 2017-2031
Table 41: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by End-user, 2017-2031
Table 42: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
List of Figures
Figure 01: Global Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, 2017-2031
Figure 02: Global Drug Discovery Outsourcing Market Value Share Analysis, by Workflow, 2022 and 2031
Figure 03: Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Workflow, 2022-2031
Figure 04: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Target Identification and Screening, 2017-2031
Figure 05: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Lead Identification and Candidate Optimization, 2017-2031
Figure 06: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Development of Disease Models, 2017-2031
Figure 07: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Pre-formulation Studies, 2017-2031
Figure 08: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Entire Clinical Trials, 2017-2031
Figure 09: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Others, 2017-2031
Figure 10: Global Drug Discovery Outsourcing Market Value Share Analysis, by Drug Molecule, 2022 and 2031
Figure 11: Global Drug Discovery Outsourcing Market Value Share Analysis, by Drug Molecule, 2022 and 2031
Figure 12: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Small Molecules, 2017-2031
Figure 13: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Large Molecules, 2017-2031
Figure 14: Global Drug Discovery Outsourcing Market Value Share Analysis, by Discovery Approach, 2022 and 2031
Figure 15: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Empirical Drug Discovery, 2017-2031
Figure 16: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Rational Drug Discovery, 2017-2031
Figure 17: Global Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2022 and 2031
Figure 18: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Anti-infective, 2017-2031
Figure 19: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Cardiovascular, 2017-2031
Figure 20: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Central Nervous System, 2017-2031
Figure 21: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Dermatology, 2017-2031
Figure 22: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Endocrine, 2017-2031
Figure 23: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Gastrointestinal, 2017-2031
Figure 24: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Genitourinary System, 2017-2031
Figure 25: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Immunomodulation, 2017-2031
Figure 26: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Oncology, 2017-2031
Figure 27: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Ophthalmology, 2017-2031
Figure 28: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Respiratory System, 2017-2031
Figure 29: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Others, 2017-2031
Figure 30: Global Drug Discovery Outsourcing Market Value Share Analysis, by Type, 2022 and 2031
Figure 31: Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Type, 2022-2031
Figure 32: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Chemistry Services, 2017-2031
Figure 33: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Biology Services, 2017-2031
Figure 34: Global Drug Discovery Outsourcing Market Value Share Analysis, by End-user, 2022 and 2031
Figure 35: Global Drug Discovery Outsourcing Market Attractiveness Analysis, by End-user, 2022-2031
Figure 36: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Pharmaceutical Companies, 2017-2031
Figure 37: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Biotechnology Companies, 2017-2031
Figure 38: Global Drug Discovery Outsourcing Market Revenue (US$ Bn), by Academic Institutes, 2017-2031
Figure 39: Global Drug Discovery Outsourcing Market Value Share Analysis, by Region, 2022 and 2031
Figure 40: Global Drug Discovery Outsourcing Market Attractiveness Analysis, by Region, 2022-2031
Figure 41: North America Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, 2017-2031
Figure 42: North America Drug Discovery Outsourcing Market Value Share Analysis, by Workflow, 2022 and 2031
Figure 43: North America Drug Discovery Outsourcing Market Attractiveness Analysis, by Workflow, 2022-2031
Figure 44: North America Drug Discovery Outsourcing Market Value Share Analysis, by Drug Molecule, 2022 and 2031
Figure 45: North America Drug Discovery Outsourcing Market Attractiveness Analysis, by Drug Molecule, 2022-2031
Figure 46: North America Drug Discovery Outsourcing Market Value Share Analysis, by Discovery Approach, 2022 and 2031
Figure 47: North America Drug Discovery Outsourcing Market Attractiveness Analysis, by Discovery Approach, 2022-2031
Figure 48: North America Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2022 and 2031
Figure 49: North America Drug Discovery Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2022-2031
Figure 50: North America Drug Discovery Outsourcing Market Value Share Analysis, by Type, 2022 and 2031
Figure 51: North America Drug Discovery Outsourcing Market Attractiveness Analysis, by Type, 2022-2031
Figure 52: North America Drug Discovery Outsourcing Market Value Share Analysis, by End-user, 2022 and 2031
Figure 53: North America Drug Discovery Outsourcing Market Attractiveness Analysis, by End-user, 2022-2031
Figure 54: North America Drug Discovery Outsourcing Market Value Share Analysis, by Country, 2022 and 2031
Figure 55: North America Drug Discovery Outsourcing Market Attractiveness Analysis, by Country, 2022-2031
Figure 56: Europe Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, 2017-2031
Figure 57: Europe Drug Discovery Outsourcing Market Value Share Analysis, by Workflow, 2022 and 2031
Figure 58: Europe Drug Discovery Outsourcing Market Attractiveness Analysis, by Workflow, 2022-2031
Figure 59: Europe Drug Discovery Outsourcing Market Value Share Analysis, by Drug Molecule, 2022 and 2031
Figure 60: Europe Drug Discovery Outsourcing Market Attractiveness Analysis, by Drug Molecule, 2022-2031
Figure 61: Europe Drug Discovery Outsourcing Market Value Share Analysis, by Discovery Approach, 2022 and 2031
Figure 62: Europe Drug Discovery Outsourcing Market Attractiveness Analysis, by Discovery Approach, 2022-2031
Figure 63: Europe Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2022 and 2031
Figure 64: Europe Drug Discovery Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2022-2031
Figure 65: Europe Drug Discovery Outsourcing Market Value Share Analysis, by Type, 2022 and 2031
Figure 66: Europe Drug Discovery Outsourcing Market Attractiveness Analysis, by Type, 2022-2031
Figure 67: Europe Drug Discovery Outsourcing Market Value Share Analysis, by End-user, 2022 and 2031
Figure 68: Europe Drug Discovery Outsourcing Market Attractiveness Analysis, by End-user, 2022-2031
Figure 69: Europe Drug Discovery Outsourcing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 70: Europe Drug Discovery Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 71: Asia Pacific Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, 2017-2031
Figure 72: Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, by Workflow, 2022 and 2031
Figure 73: Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, by Workflow, 2022-2031
Figure 74: Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, by Drug Molecule, 2022 and 2031
Figure 75: Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, by Drug Molecule, 2022-2031
Figure 76: Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, by Discovery Approach, 2022 and 2031
Figure 77: Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, by Discovery Approach, 2022-2031
Figure 78: Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2022 and 2031
Figure 79: Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2022-2031
Figure 80: Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, by Type, 2022 and 2031
Figure 81: Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, by Type, 2022-2031
Figure 82: Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, by End-user, 2022 and 2031
Figure 83: Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, by End-user, 2022-2031
Figure 84: Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 85: Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 86: Latin America Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, 2017-2031
Figure 87: Latin America Drug Discovery Outsourcing Market Value Share Analysis, by Workflow, 2022 and 2031
Figure 88: Latin America Drug Discovery Outsourcing Market Attractiveness Analysis, by Workflow, 2022-2031
Figure 89: Latin America Drug Discovery Outsourcing Market Value Share Analysis, by Drug Molecule, 2022 and 2031
Figure 90: Latin America Drug Discovery Outsourcing Market Attractiveness Analysis, by Drug Molecule, 2022-2031
Figure 91: Latin America Drug Discovery Outsourcing Market Value Share Analysis, by Discovery Approach, 2022 and 2031
Figure 92: Latin America Drug Discovery Outsourcing Market Attractiveness Analysis, by Discovery Approach, 2022-2031
Figure 93: Latin America Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2022 and 2031
Figure 94: Latin America Drug Discovery Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2022-2031
Figure 95: Latin America Drug Discovery Outsourcing Market Value Share Analysis, by Type, 2022 and 2031
Figure 96: Latin America Drug Discovery Outsourcing Market Attractiveness Analysis, by Type, 2022-2031
Figure 97: Latin America Drug Discovery Outsourcing Market Value Share Analysis, by End-user, 2022 and 2031
Figure 98: Latin America Drug Discovery Outsourcing Market Attractiveness Analysis, by End-user, 2022-2031
Figure 99: Latin America Drug Discovery Outsourcing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 100: Latin America Drug Discovery Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 101: Middle East & Africa Drug Discovery Outsourcing Market Value (US$ Bn) Forecast, 2017-2031
Figure 102: Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, by Workflow, 2022 and 2031
Figure 103: Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis, by Workflow, 2022-2031
Figure 104: Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, by Drug Molecule, 2022 and 2031
Figure 105: Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis, by Drug Molecule, 2022-2031
Figure 106: Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, by Discovery Approach, 2022 and 2031
Figure 107: Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis, by Discovery Approach, 2022-2031
Figure 108: Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, by Therapeutic Area, 2022 and 2031
Figure 109: Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2022-2031
Figure 110: Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, by Type, 2022 and 2031
Figure 111: Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis, by Type, 2022-2031
Figure 112: Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, by End-user, 2022 and 2031
Figure 113: Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis, by End-user, 2022-2031
Figure 114: Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 115: Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security